I am fairly certain that as far as CTIX goes this will go down as a buying opportunity. This is my last post about this issue...I think Leo says it best (I have added emphasis):
Hi XXX,
First the article linked in the SA article about Dr Menon is completely false and was removed from the web by that publication. Think about it, long after the article was first published Dr Frei made public statements applauding our work on kevetrin and his association with CTIX. The CV on Dr Menon is correct on our website.
By trying to hurt NNVC he is dragging in CTIX. I seem to remember once getting solicited by the Brian mentioned in the article but I passed on his offer.
Regarding promotion, our efforts are limited to press releases. I do not know or have ever heard of Dyman Associates. I wouldnt trust the source
I am now overseas on CTIX business and will be returning next week.
Best
Leo Ehrlich